SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-24-002130
Filing Date
2024-03-04
Accepted
2024-03-04 18:01:28
Documents
1
Period of Report
2024-03-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4209
  Complete submission text file 0001562180-24-002130.txt   5784
Mailing Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805
Business Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805 (302) 467-1280
Prelude Therapeutics Inc (Issuer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE CAMANA BAY, GRAND CAYMAN E9 KY1-1108
Business Address
Huang Jane (Reporting) CIK: 0001683913 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39527 | Film No.: 24716877